In this study, we use our approach to building a descriptively probabilistic relationship between mutated primary structure of
coagulation factor IX and clinical severity of hemophilia B.
Efficacy and safety of recombinant fusion protein linking
coagulation factor IX with albumin (rIX-FP) in previously treated patients with hemophilia B undergoing major orthopedic surgeries.
IXINITY
coagulation factor IX (recombinant) and any and all Emergent BioSolutions Inc.
examines applications of
Coagulation Factor IX and its consumers
Concentrate recombinant
coagulation factor IX, a minimum of second generation in the number of 60 000 IU
GTC previously obtained from ProGenetics an exclusive license to a number of recombinant plasma proteins, including human
coagulation factor IX, for North America, Europe and Japan.
24, 2013 /PRNewswire/ -- The agreement covers the commercial manufacture of a monoclonal antibody used for the recovery and purification of
coagulation factor IX from human blood.
Biovitrum (STO:BVT) today announced it has entered into a new agreement, effective August 8, 2007, with Wyeth (NYSE:WYE) to co-promote BeneFIX[R],
Coagulation Factor IX (Recombinant) for hemophilia B, in the Nordic countries (Denmark, Finland, Iceland, Norway and Sweden).
20 80 9 33621000-9
Coagulation Factor Ix 1200 Iu Vial with Solvent Vial Factor Ix + 4:16
AMSTERDAM, July 3, 2013 /PRNewswire/ -- Data presented by CSL Behring today showed clinical efficacy of a once-weekly dosing regimen of recombinant fusion protein linking
coagulation Factor IX with albumin (rIX-FP).
Tenders are invited for Acquisition of
Coagulation Factor IX Nonacog Alfa
AMSTERDAM, July 3, 2013 /PRNewswire/ -- CSL Behring today presented a population pharmacokinetic model for recombinant fusion protein linking
coagulation factor IX with albumin (rIX-FP) at the International Society on Thrombosis and Haemostasis (ISTH) congress in Amsterdam.
Hemophilia B (Christmas disease) is a rare, potentially life threatening, congenital bleeding disorder resulting from a defect or deficiency in blood
coagulation factor IX.
Human
Coagulation Factor Ix 4 600 Iu Vial Lyophilized Lot.
Efficacy, PK and Safety Results of a Phase I/II Clinical Trial of Recombinant Fusion Protein Linking
Coagulation Factor IX with Albumin (rIX-FP) in Previously Treated Patients with Hemophilia B (PROLONG - 9FP)(U.
